Hepatitis Forums
Hepatitis C Main Forums => Hepatitis C Research News & Studies => Topic started by: Hep Editors on December 04, 2019, 10:40:58 am
-
Harvoni (ledipasvir/sofosbuvir) proved safe, well tolerated and highly effective against hepatitis C virus (HCV) in a small study of children who contracted the virus from their mothers and who were at least three years old but younger than six years old.
Kathleen B. Schwartz, MD, of the department of pediatrics at Johns Hopkins University School of Medicine led a research team that conducted a multicenter, open-label Phase II study of 12 weeks of Harvoni among 34 children with hep C in that age range. They published their findings in the journal Hepatology.
Read more...
https://www.hepmag.com/article/harvoni-safe-effective-treating-hep-c-3-5yearolds